Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases

Journal of Periodontal Research

Volumn 42, Issue 4, 2007, Pages 287-293

  Bostanci, N ^a,b   Ilgenli, T ^a   Emingil, G ^a   Afacan, B ^a   Han, B ^a   Toz H ^a   Berdeli, A ^a   Atilla, G ^a   McKay, I J ^b   Hughes, F J ^b   Belibasakis, G N ^b  

^a EGE UNIVERSITY   (Turkey)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bone resorption; Gingival tissue; Osteoprotegerin; Receptor activator of nuclear factor B ligand

Indexed keywords

MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC DISEASE; CLASSIFICATION; FEMALE; GINGIVA; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTAL DISEASE; PERIODONTICS; PERIODONTITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GINGIVA; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; OSTEOPROTEGERIN; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTITIS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 34250183127     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00946.x     Document Type: Article

References (35)

1. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000 289 : 1504 1508.
2. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004 15 : 457 475.
3. Valverde P, Kawai T, Taubman MA. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. J Bone Miner Res 2004 19 : 155 164.
4. Teng YT, Nguyen H, Gao X et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000 106 : R59 R67.
5. Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun 1999 265 : 144 150.
6. Taubman MA, Valverde P, Han X, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol 2005 76 : 2033 2041.
7. Kong YY, Feige U, Sarosi I et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999 402 : 304 309.
8. Sakurai A, Okahashi N, Nakagawa I et al. Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand. Infect Immun 2003 71 : 6019 6026.
9. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003 423 : 356 361.
10. Garlet GP, Martins W Jr., Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004 31 : 671 679.
11. Crotti T, Smith MD, Hirsch R et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodont Res 2003 38 : 380 387.
12. Mogi M, Otogoto J, Ota N, Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004 83 : 166 169.
13. Liu D, Xu JK, Figliomeni L et al. Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. Int J Mol Med 2003 11 : 17 21.
14. Saether K, Tollefsen T, Helgeland K, Schenck K. The gingival plasma cell infiltrate in renal transplant patients on an immunosuppressive regimen. Acta Odontol Scand 1998 56 : 281 287.
15. Fischer RG, Edwardsson S, Klinge B, Attstrom R. The effect of cyclosporin-A on the oral microflora at gingival sulcus of the ferret. J Clin Periodontol 1996 23 : 853 860.
16. Nassar CA, Nassar PO, Abi Rached RS, Holzhausen M, Marcantonio E Jr., Spolidorio LC. Effect of cyclosporin A on alveolar bone homeostasis in a rat periodontitis model. J Periodont Res 2004 39 : 143 148.
17. Tollefsen T, Johansen JR. The periodontal status of prospective and renal transplant patients. Comparison with systemically healthy subjects. J Periodont Res 1985 20 : 220 226.
18. Spolidorio LC, Spolidorio DM, Holzhausen M. Effects of long-term cyclosporin therapy on the periodontium of rats. J Periodont Res 2004 39 : 257 262.
19. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999 4 : 1 6.
20. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med 2001 12 : 125 135.
21. Nagasawa T, Kobayashi H, Kiji M et al. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 2002 130 : 338 344.
22. Darveau RP, Tanner A, Page RC. The microbial challenge in periodontitis. Periodontol 2000 1997 14 : 12 32.
23. Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner UH. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005 73 : 342 351.
24. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987 14 : 610 613.
25. Hayes JM. The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation. J Urol 1993 149 : 437 448.
26. Orcel P, Denne MA, de Vernejoul MC. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology 1991 128 : 1638 1646.
27. Awumey EM, Moonga BS, Sodam BR et al. Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption. Biochem Biophys Res Commun 1999 254 : 248 252.
28. Fuller K, Kirstein B, Chambers TJ. Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 2006 147 : 1979 1985.
29. Ishida N, Hayashi K, Hoshijima M et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 2002 277 : 41147 41156.
30. Tamler R, Epstein S. Nonsteroid immune modulators and bone disease. Ann NY Acad Sci 2006 1068 : 284 296.
31. Malyszko J, Malyszko JS, Wolczynski S, Mysliwiec M. Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. Transplant Proc 2003 35 : 2227 2229.
32. Miyazaki M, Fujikawa Y, Takita C, Tsumura H. Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis. Clin Rheumatol 2006 (in press).
33. Hofbauer LC, Shui C, Riggs BL et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001 280 : 334 339.
34. Humphrey EL, Williams JH, Davie MW, Marshall MJ. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 2006 38 : 652 661.
35. Kotake S, Udagawa N, Hakoda M et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum 2001 44 : 1003 1012.